Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Teva Pharmaceuticals Ireland .
Filed returns
7
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| May–Aug 2025 | Teva Pharmaceuticals Ireland | Economic Development and Industry | Meeting request with Minister Burke (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2024 | Teva Pharmaceuticals Ireland | Health | Difficulties launching generics (Matters involving public funds) | 1 | On lobbying.ie |
| May–Aug 2024 | Teva Pharmaceuticals Ireland | Health | EU Pharma Strategy (Legislation) | 1 | On lobbying.ie |
| May–Aug 2024 | Teva Pharmaceuticals Ireland | Health | Urban Wastewater Treatment Directive (UWWTD) (Legislation) | 4 | On lobbying.ie |
| Jan–Apr 2024 | Teva Pharmaceuticals Ireland | Health | Engagement Security of medicine supply and EU Pharma Legislation (Legislation) | 1 | On lobbying.ie |
| Jan–Apr 2021 | Teva Pharmaceuticals Ireland | Health | Briefing Deputy Alan Kelly on the status of the migraine treatment Fremanezumab and the need for clarity and transparency around timelines for approval for reimbursement. (Matters involving public funds) | 1 | On lobbying.ie |
| May–Aug 2020 | Teva Pharmaceuticals Ireland | Health | A letter to the Minister for Health seeking a meeting to discuss the upcoming European Pharmaceutical Strategy and to discuss how best Teva Pharmaceuticals could support Ireland’s input into the strategy formation. (Public policy or programme) | 1 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 6 | 85.7% | |
| Economic Development and Industry | 1 | 14.3% |